Megan Settle
Impact in
- Clinical Biochemistry top 2%
- Paraoxonase enzyme and polymorphisms
- Immunology top 5%
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Atherosclerosis and Cardiovascular Diseases
Papers in
-
- Peroxisome Proliferator-Activated Receptors 6
-
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 3
- Atherosclerosis and Cardiovascular Diseases 3
- Co-authors
- Jonathan D. Smith (9 shared papers)Michael Kinter (4 shared papers)Lemin Zheng (4 shared papers)Stanley L. Hazen (4 shared papers)Xiaoming Fu (2 shared papers)Marlene Goormastic (2 shared papers)Mingjiang Sun (2 shared papers)Leonor Thomson (2 shared papers)
- Journals
- Journal of Lipid Research (2 papers)Journal of Clinical Investigation (2 papers)Journal of Biological Chemistry (2 papers)Arteriosclerosis Thrombosis and Vascular Biology (2 papers)Mammalian Genome (1 paper)
- Partner nations
- United StatesIndiaFrance
In The Last Decade
Megan Settle
11 papers receiving 1.7k citations
Megan Settle's Hit Papers
Peers
Comparison fields: 5 of 92
- Clinical Biochemistry 255
- Immunology 604
- Endocrinology, Diabetes and Metabolism 443
- Biochemistry 124
- Surgery 659
Countries citing papers authored by Megan Settle
This map shows the geographic impact of Megan Settle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Megan Settle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Megan Settle more than expected).
Fields of papers citing papers by Megan Settle
This network shows the impact of papers produced by Megan Settle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Megan Settle. The network helps show where Megan Settle may publish in the future.
Co-authors
The 25 scholars most cited alongside Megan Settle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease Hit paper breakdown → | 2004 | 577 |
| 2 | Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease Hit paper breakdown → | 2004 | 563 |
| 3 | 2004 | 173 | |
| 4 | 2004 | 111 | |
| 5 | 2004 | 72 | |
| 6 | 2005 | 67 | |
| 7 | 2014 | 65 | |
| 8 | 2005 | 43 | |
| 9 | 2005 | 40 | |
| 10 | 2000 | 20 | |
| 11 | 2006 | 16 |
About Megan Settle
Megan Settle is a scholar working on Molecular Biology, Immunology, Surgery, Physiology and Oncology, having authored 11 papers that have together received 1.7k indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (6 papers), Cholesterol and Lipid Metabolism (4 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers), Atherosclerosis and Cardiovascular Diseases (3 papers), Nitric Oxide and Endothelin Effects (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Advanced Glycation End Products research (2 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (1 paper). The work is most often cited by research in Clinical Biochemistry (255 citations), Immunology (604 citations), Endocrinology, Diabetes and Metabolism (443 citations), Biochemistry (124 citations) and Surgery (659 citations). Megan Settle has collaborated with scholars based in United States, India and France. Frequent co-authors include Jonathan D. Smith, Michael Kinter, Lemin Zheng, Stanley L. Hazen, Xiaoming Fu, Marlene Goormastic, Mingjiang Sun, Leonor Thomson, Harry Ischiropoulos and Paul L. Fox. Their work appears in journals such as Journal of Lipid Research, Journal of Clinical Investigation, Journal of Biological Chemistry, Arteriosclerosis Thrombosis and Vascular Biology and Mammalian Genome.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.